MedTrace Logo

Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCC

NCT05059665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2021-11-05

No results posted yet for this study

Summary

De-identified whole blood and serum samples are collected for the purpose of evaluating the performance (sensitivity/specificity) of the HelioLiver Test for the detection of hepatocellular carcinoma (HCC).

Conditions

  • Hepatocellular Carcinoma by AJCC Stage

Interventions

DIAGNOSTIC_TEST

Helio Liver Test

De-identified whole blood and serum samples are collected for the purpose of evaluating the performance (sensitivity/specificity) of the HelioLiver Test for the detection of hepatocellular carcinoma (HCC).

Sponsors & Collaborators

  • Laboratory for Advanced Medicine, Guangzhou

    collaborator UNKNOWN

  • Helio Health Inc., Irvine, CA

    collaborator UNKNOWN

  • Helio Genomics

    lead INDUSTRY

Principal Investigators

  • RIchard Van Etten, MD, PhD · University of California, Irvine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05059665 on ClinicalTrials.gov